Central IRB Services for NIAID Coronavirus COVID-19 OWS ACTIV-3 Clinical Trial

Program Manager:

Active Dates:

March 30, 2020 -- March 29, 2021

Awarded Amount:

$718,961

Investigator(s):

Awardee Organization:

MEDICAL SCIENCE & COMPUTING, LLC
Maryland

Funding ICs:

National Institute of Allergy and Infectious Diseases (NIAID)

Abstract:

The purpose of this funding is to provide the Central Institutional Review Board (IRB) services for the Coronavirus COVID-19 ACTIV-3 trial.